Neuroimaging techniques - Improving diagnostic and therapeutic options in acute stroke

Acta Clinica Croatica

Volumn 45, Issue 4, 2006, Pages 331-341

  Vuković, Vlasta ^a,d   Molina, Carlos A ^b,c   Ribo, Mark ^b,c   Lovrenčić Huzjan, Arijana ^a   Budišić, Mislav ^a   Demarin, Vida ^a  

^a University Department of Neurology   (Croatia)

^b Institute of Anthropology   (Croatia)

^c UNIVERSITY OF BARCELONA   (Spain)

^d SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Brain ischemia diagnosis; Brain ischemia physiopathology; Cerebrovascular accident diagnosis; Cerebrovascular accident ultrasonography

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; TICLOPIDINE;

BRAIN ANGIOGRAPHY; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; DRUG EFFICACY; HEMODYNAMICS; HUMAN; MIDDLE CEREBRAL ARTERY; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PATIENT SELECTION; RADIODIAGNOSIS; RECANALIZATION; REVIEW; SENSITIVITY AND SPECIFICITY; STROKE; VASOMOTOR REFLEX;

EID: 33847791444     PISSN: 03539466     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. ZANETTE EM, ROBERTI C, MANCINI G, POZZLI C, BRAGONI M, TONI D. Spontaneous middle cerebral artery reperfusion in ischemic stroke: a follow-up study with transcranial Doppler. Stroke 1995;26:430-3.
2. The National Institutes of Neurological Disorders, and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
3. HACKE W, DONNAN G, FIESCHIC, KASTE M, von KUMMER R, BRODERICK JP, BROTT T, FRANKEL M, GROTTA JC, HALEY EC Jr, KWIATKOWSKI T, LEVINE SR, LEWANDOWSKI C, LU M, LYDEN P, MARLER JR, PATEL S, TILLEY BC, ALBERS G, BLUHMKI E, WILHELM M, HAMILTON S; ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and rt-PA stroke trials. Lancet 2004;363:768-74.
4. ALEXANDROV AV, DEMARIN D. Insonation techniques and diagnostic criteria for transcranial Doppler sonography. Acta Clin Croat 1999;38:97-108.
5. Newell DW, Aaslid R, eds. Transcranial Doppler. New York: Raven Press, 1992.
6. VUKOVIĆ V, LOVRENČIĆ-HUZJAN A, DEMARIN V. Microembolus detection by transcranial Doppler sonography - technical and clinical aspects. Acta Clin Croat 2005;44:33-45.
7. ZAVOREO I, DEMARIN V. Breath holding index in the evaluation of cerebral vasoreactivity. Acta Clin Croat 2004;43:15-9.
8. DEMCHUK AM, BURGIN WS, CHRISTOU I, FELBERG RA, BARBER PA, HILL MD, ALEXANDROV AV. Thrombolysis in brain ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator. Stroke 2001;32:89-93.
9. BURGIN WS, MALKOFF M, DEMCHUK AM, FELBERG RA, CHRISTOU I, GROTTA JC, ALEXANDROV AV. Transcranial Doppler ultrasound criteria for recanalization after thrombolysis for middle cerebral artery stroke. Stroke 2000;31:1128-32.
10. DEMCHUK AM, CHRISTOU I, WIEN TH, FELBERG RA, MALKOFF M, GROTTA JC, ALEXANDROV AV. Specific transcranial Doppler flow findings related to the presence and site of arterial occlusion with transcranial Doppler. Stroke 2000;31:140-6.
11. MILLAN M, DAVALOS A. The need for new therapies for acute ischaemic stroke. Cerebrovasc Dis 2006;22 (Suppl 1):3-9.
12. ALEXANDROV AV, BURGIN SW, DEMCHUK AM, El-MITWALLI A, GROTTA JC. Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement. Circulation 2001;103:2897-902.
13. BLINC A, PLANINSIC G, KEBER D, JARH O, LAHAJNAR G, ZIDANSEK A, DEMSAR F. Dependence of blood clot lysis on the mode of transport of urokinase into the clot: a magnetic resonance imaging study in vitro. Thromb Haemost 2001;65:549-52.
14. BLINC A, KEBER D, LAHANAJNAR GSTEGBAR M, ZIDANSEK A, DEMSAR F. Lysing patterns of retracted blood clots with diffusion or bulk flow transport of plasma with urokinase into clots: a magnetic resonance imaging study in vitro. Thromb Haemost 1992;68:667-71.
15. MOLINA CA, MONTANER J, ARENILLAS JF, RIBO M, RUBIERA M, ALVAREZ-SABIN J. Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes. Stroke 2004;35:486-90.
16. RIBO M, ALVAREZ-SABIN J, MONTANER J, ROMERO F, DELGADO P, RUBIERA M, DELGADO-MEDEROS R, MOLINA CA. Temporal profile of recanalization after intravenous tissue plasminogen activator. Selecting patients for rescue reperfusion techniques. Stroke 2006;37:1000-4.
17. ALEXANDROV AV, GROTTA JC. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 2002;56:568-70.
18. RUBIERA M, ALVAREZ-SABIN J, RIBO M, MONTANER J, SANTAMARINA E, ARENILLAS JF, HUERTAS R, DELGADO P, PURROY F, MOLINA CA. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke. Stroke 2005;36:1452-6.
19. del ZOPPO GJ, POECK K, PESSIN MS, WOLPERT SM, FURLAN AJ, FERBERT A, ALBERTS MJ, ZIVIN JA, WECHSLER L, BUSSE O et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992;32:78-86.
20. SAQQUR M, SHUAIB A, ALEXANDROV AV, HILL MD, CALLEJA S, TOMSICK T, BRODERICK J, DEMCHUK A. Derivation of transcranial Doppler criteria for rescue intra-arterial thrombolysis. Stroke 2005;36:865-8.
21. CHERNYSHEV O, GARAMI Z, CALLEJA S, SONG J, CAMPBELL MS, NOSER E, SHALTONI H, CHEN CHI, IGUCHI Y, GROTTA J, ALEXANDROV AV. Yield and accuracy of urgent combined carotid/transcranial ulstrasound testing in acute cerebral ischemia. Stroke 2005;36:32-7.
22. RUDOLF J, NEVELING M, GROND M, SCHMULLING S, STENZEL C, HEISS WD. Stroke following internal carotid occlusion: a contra-indication for intravenous thrombolysis? Eur J Neurol 1999;6:51-5.
23. TROUILLAS P, NIGHOGHOSSIAN N, DEREX L, ADELEINE P, HONNORAT J, NEUSCHWANDER P, RICHIE G, GETENET JC, LI W, FROMENT JC et al. Thrombolysis with intravenous rt-PA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors. Stroke 1998;29:2529-40.
24. LOVRENCIĆ-HUZJAN A, BOSNAR-PURETIĆ M, VUKOVIĆ V, MALIĆ M, THALLER N, DEMARIN V. Correlation of carotid color Doppler and angiographic findings in patients with symptomatic carotid artery stenosis. Acta Clin Croat 2000;39:215-20.
25. CHRISTOU I, FELBERG RA, DEMCHUK AM, GROTTA JC, BURGIN WS, MALKOFF M, ALEXANDROV AV. Accuracy parameters of a broad diagnostic battery for bedside transcranial Doppler to detect flow changes with internal carotid artery stenosis or occlusion. J Neuroimaging 2001;11:236-42.
26. El-MITWALLI A, SAAD M, CHRISTOU I, MALKOFF M, ALEXANDROV AV. Clinical and sonographic pattern of tandem internal carotid artery/middle cerebral artery occlusion in tissue plasminogen activator-treated patients. Stroke 2002;33:99-102.
27. FIEBACH JB, SCHELLINGER PD, JANSEN O, MEYER M, WILDE P, BENDER J, SCHRAMM P, JUTTLER E, OEHLER J, HARTMANN M, HAHNEL S, KNAUTH M, HACKE W, SARTOR K. CT and diffusion-weighted MR imaging in randomized order: diffusion-weighted imaging results in higher accuracy and lower interrater variablity in the diagnosis of hyperacute ischemic stroke. Stroke 2003;34:1235-41.
28. WINTERMARK M, REICHHART M, THIRAN JP, MAEDER P, CHALARON M, SCHNYDER P, BOGOUSSLAVSKY J, MEULLI R. Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann Neurol 2002;51:417-32.
29. KIDWELL CS, ALGER JR, SAVER JL. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 2003;34:2729-35.
30. MAARTEN GL, GREGORY WA, BEAULIEU CA, MARKS MP. Comparison of diffusion-weighted MRI and CT in acute stroke. Neurology 2000;54:1557-61.
31. LARRUE V, von KUMMER RR, MULLER A, BLUHMKIE. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 2001;32:438-41.
32. TONG DC, YENARI MA, ALBERS GW, O'BRIEN M, MARKS MP, MOSELY ME. Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke. Neurology 1998;4:864-70.
33. THIJS VN, ADAMI A, NEUMANN-HAEFELIN T, MOSELEY ME, MARKS MP, ALBERS GW. Relationship between severity of MR perfusion deficit and DWI lesion evolution. Neurology 2001;57:1206-11.
34. RIBO M, MOLINA CA, ROVIRA A, QUINTANA M, DELGADO P, MONTANER J, GRIVE E, ARENILLAS JF, ALVAREZ-SABIN J. Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal Doppler/MRI selection protocol. Stroke 2005;36:602-6.
35. MOLINA CA, SAVER JL. Extending reperfusion therapy for acute ischemic stroke. Emerging pharmacological, mechanical and imaging strategies. Stroke 2005;36:2311-20.
36. DAVALOS A, LEIRA R, PEDRAZA S, CASTELLANOS M, SILVA Y, MONTSERRAT P et al. The clinical-DWI mismatch: a new diagnostic clue in the treatment of acute ischemic stroke. Stroke 2003;34:254A.
37. SCHRAMM P, SCHELLINGER PD, KLOTZ E, KALLENBERG K, FIEBACH JB, KULKENS S, HEILAND S, KNAUTH M, SARTOR K. Comparison of perfusion computed tomography and computed tomography angiography source images with perfusion-weighted imaging and diffusion-weighted imaging in patients with acute stroke of <6 hour duration. Stroke 2004;35:1652-8.
38. ALEXANDROV AV, MOLINA CA, GROTTA JC, GARAMI Z, FORD SR, ALVAREZ-SABIN J, MONTANER J, SAQQUR M, DEMCHUK AM, MOVE LA, HILL MD, WOJNER AW, for the CLOTBUST Investigators. Ultrasound-enhanced thrombolysis for acute ischemic stroke. N Engl J Med 2004;351:2170-8.
39. FRANCIS CW, BLINC A, LEES S, COX C. Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. Ultrasound Med Biol 1995;21:419-24.
40. DAFFERTSHOFER M, GRASS A, RINGLEB P, SITZER M, SLIWKA U, ELS T, SEDLACZEK O, KOROSHETZ WJ, HENNERICI MG. Transcranial low-frequency ultrasound-mediated thrombolysis in brain: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II clinical trial. Stroke 2005;36:1441-6.
41. MOLINA CA, RIBO M, RUBIERA M, MONTANER J, SANTAMARINA E, DELGADO-MEDEROS R, ARENILLAS JF, HUERTAS R, PURROY F, DELGADO P, ALVAREZ-SABIN J. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke 2006;37:425-9.
42. CULP WC, PORTER TR, LOWERY J, XIE F, ROBERTSON PK, MARKY L. Intracranial clot lysis with intravenous microbubbles and transcranial ultrasound in swine. Stroke 2004;35:2407-11.
43. CINTAS P, NGUYEN F, BONEU B, LARRUE V. Enhancement of enzymatic fibrinolysis with 2-MHz ultrasound and microbubbles. J Thromb Haemost 2004;2:1163-6.
44. VIGUIER A, PETIT R, RIGAL M, CINTAS P, LARRUE V. Continuous monitoring of middle cerebral artery recanalization with transcranial color-coded sonography and Levovist. J Thromb Thrombolysis 2005;19:55-9.
45. ALBERTS MJ, LATCHAW RE, SELMAN WR, SHEPARD T, HADLEY MN, BRASS LM, KOROSHETZ W, MAKLER JR, BOOSS J, ZOROWITZ RD, CROFT JB, MAGNIS E, MULLIGAN D, JAGODA A, O'CONNOR R, COWLEY M, CONNORS JJ, ROSEDE-RENZY JA, EMR M, WARREN MD, WALKER MD, for the Brain Attack Coalition, Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke 2005;36:1597-618.